Home / Inspections / 1181741

FDA Inspection 1181741 — Jubilant HollisterStier General Partnership

Jubilant HollisterStier General Partnership — FEI 3001623073

The FDA completed an inspection of Jubilant HollisterStier General Partnership on October 7, 2022 in Kirkland. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 7, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Kirkland (Canada)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1289886 (OAI Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1242347 (OAI Fri Jun 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1054645 (VAI Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 953135 (VAI Thu Dec 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 850579 (VAI Thu Sep 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources